{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:53:29Z","timestamp":1791777209989,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T00:00:00Z","timestamp":1348617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1245\/s10434-012-2669-8","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T02:52:57Z","timestamp":1348627977000},"page":"864-871","source":"Crossref","is-referenced-by-count":69,"title":["Elevated CEA Levels and Low Distance of the Tumor from the Anal Verge are Predictors of Incomplete Response to Chemoradiation in Patients with Rectal Cancer"],"prefix":"10.1245","volume":"20","author":[{"given":"Angelo","family":"Restivo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Zorcolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana Maria Francesca","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Manunza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Margiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Casula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,26]]},"reference":[{"key":"2669_CR1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","volume":"345","author":"E Kapiteijn","year":"2001","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638\u201346.","journal-title":"N Engl J Med."},{"key":"2669_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000658-199002000-00011","volume":"211","author":"L Pahlman","year":"1990","unstructured":"Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990;211:187\u201395.","journal-title":"Ann Surg."},{"key":"2669_CR3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731\u201340.","journal-title":"N Engl J Med."},{"key":"2669_CR4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(96)05348-2","volume":"348","author":"MRCRC Working Party","year":"1996","unstructured":"MRCRC Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet. 1996;348:1605\u201310.","journal-title":"Lancet."},{"key":"2669_CR5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cncr.11075","volume":"97","author":"CH Crane","year":"2003","unstructured":"Crane CH, Skibber JM, Feig BW, Vauthey JN, Thames HD, Curley SA, et al. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003;97:517\u201324.","journal-title":"Cancer."},{"key":"2669_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cncr.23516","volume":"113","author":"H Quah","year":"2008","unstructured":"Quah H, Chou J, Gonen M, Shia J, Schrag D, Saltz LB, et al. Pathologic stage is most prognostic of disease\u2010free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer. 2008;113:57\u201364.","journal-title":"Cancer."},{"key":"2669_CR7","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"C Rodel","year":"2005","unstructured":"Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23:8688\u201396.","journal-title":"J Clin Oncol."},{"key":"2669_CR8","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"27","author":"MS Roh","year":"2009","unstructured":"Roh MS, Colangelo LH, O\u2019Connell MJ, Yothers G, Deutsch M, Allegra CJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27:5124\u201330.","journal-title":"J Clin Oncol."},{"key":"2669_CR9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1245\/ASO.2006.03.053","volume":"13","author":"F Stipa","year":"2006","unstructured":"Stipa F, Chessin D, Shia J, Paty PB, Weiser M, Temple LK, et al. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol. 2006;13:1047\u201353.","journal-title":"Ann Surg Oncol."},{"key":"2669_CR10","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/annonc\/mdi212","volume":"16","author":"C Aschele","year":"2005","unstructured":"Aschele C, Friso ML, Pucciarelli S, Lonardi S, Sartor L, Fabris G, et al. A phase I\u2013II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol. 2005;16:1140\u20136.","journal-title":"Ann Oncol."},{"key":"2669_CR11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/annonc\/mdn719","volume":"20","author":"C Carlomagno","year":"2009","unstructured":"Carlomagno C, Farella A, Bucci L, D\u2019Armiento FP, Pesce G, Pepe S, et al. Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. Ann Oncol. 2009;20:906\u201312.","journal-title":"Ann Oncol."},{"key":"2669_CR12","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/cncr.22625","volume":"109","author":"P Das","year":"2007","unstructured":"Das P, Skibber J, Rodriguez-Bigas M, Feig BW, Chang GJ, Wolff RA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007;109:1750\u20135.","journal-title":"Cancer."},{"key":"2669_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1245\/ASO.2005.03.044","volume":"12","author":"S Pucciarelli","year":"2005","unstructured":"Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, et al. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol. 2005;12:111\u20136.","journal-title":"Ann Surg Oncol."},{"key":"2669_CR14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF02234323","volume":"44","author":"TE Read","year":"2001","unstructured":"Read TE, McNevin MS, Gross EK, Whiteford HM, Lewis JL, Ratkin G, et al. Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity. Dis Colon Rectum. 2001;44:513\u201322.","journal-title":"Dis Colon Rectum."},{"key":"2669_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3816\/CCC.2006.n.012","volume":"5","author":"R Rengan","year":"2006","unstructured":"Rengan R, Paty PB, Wong WD, Guillem JG, Weiser M, Temple L, et al. Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders. Clin Colorectal Cancer. 2006;5:413\u201321.","journal-title":"Clin Colorectal Cancer."},{"key":"2669_CR16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.2006.08.3675","volume":"25","author":"C Rodel","year":"2007","unstructured":"Rodel C, Liersch T, Hermann RM, Arnold D, Reese T, Hipp M, et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol. 2007;25:110\u20137.","journal-title":"J Clin Oncol."},{"key":"2669_CR17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijrobp.2008.05.054","volume":"72","author":"DI Rosenthal","year":"2008","unstructured":"Rosenthal DI, Catalano PJ, Haller DG, Landry JC, Sigurdson ER, Spitz FR, et al. Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3\/T4 rectal adenocarcinoma: ECOG E1297. Int J Radiat Oncol Biol Phys. 2008;72:108\u201313.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2669_CR18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.amjsurg.2006.09.030","volume":"193","author":"AT Shivnani","year":"2007","unstructured":"Shivnani AT, Small W, Jr., Stryker SJ, Kiel KD, Lim S, Halverson AL, et al. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg. 2007;193:389\u201393; discussion 393\u20134.","journal-title":"Am J Surg."},{"key":"2669_CR19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/SLA.0b013e3181b91e63","volume":"250","author":"M Kalady","year":"2009","unstructured":"Kalady M, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg. 2009;250:582\u20139.","journal-title":"Ann Surg."},{"key":"2669_CR20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.bjc.6605105","volume":"101","author":"M Kikuchi","year":"2009","unstructured":"Kikuchi M, Mikami T, Sato T, Tokuyama W, Araki K, Watanabe M, et al. High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. Br J Cancer. 2009;101:116\u201323.","journal-title":"Br J Cancer."},{"key":"2669_CR21","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s10350-007-277-7","volume":"50","author":"IJ Kim","year":"2007","unstructured":"Kim IJ, Lim S, Kang HC, Chang HJ, Ahn SA, Park HW, et al. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum. 2007;50:1342\u201353.","journal-title":"Dis Colon Rectum."},{"key":"2669_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjc.6604131","volume":"98","author":"FV Negri","year":"2008","unstructured":"Negri FV, Campanini N, Camisa R, Pucci F, Bui S, Ceccon G, et al. Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. Br J Cancer. 2008;98:143\u20137.","journal-title":"Br J Cancer."},{"key":"2669_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","volume":"72","author":"K Bujko","year":"2004","unstructured":"Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pude\u0142ko M, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol. 2004;72:15\u201324.","journal-title":"Radiother Oncol."},{"key":"2669_CR24","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1200\/JCO.1999.17.8.2396","volume":"17","author":"Y Francois","year":"1999","unstructured":"Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol. 1999;17:2396.","journal-title":"J Clin Oncol."},{"key":"2669_CR25","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00464-009-0349-y","volume":"23","author":"L Zorcolo","year":"2009","unstructured":"Zorcolo L, Fantola G, Cabras F, Marongiu L, D\u2019Alia G, Casula G. Preoperative staging of patients with rectal tumors suitable for transanal endoscopic microsurgery (TEM): comparison of endorectal ultrasound and histopathologic findings. Surg Endosc. 2009;23:1384\u20139.","journal-title":"Surg Endosc."},{"key":"2669_CR26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jso.20320","volume":"93","author":"YA Park","year":"2006","unstructured":"Park YA, Sohn SK, Seong J, Baik SH, Lee KY, Kim NK, et al. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. J Surg Oncol. 2006;93:145\u201350.","journal-title":"J Surg Oncol."},{"key":"2669_CR27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ijrobp.2007.04.047","volume":"69","author":"SM Yoon","year":"2007","unstructured":"Yoon SM, Kim D, Kim TH, Jung KH, Chang HJ, Koom WS, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2007;69:1167\u201372.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2669_CR28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/DCR.0b013e31819ef76b","volume":"52","author":"RO Perez","year":"2009","unstructured":"Perez RO, S\u00e3o Juli\u00e3o GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG, et al. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum. 2009;52:1137\u201343.","journal-title":"Dis Colon Rectum."},{"key":"2669_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejso.2004.08.002","volume":"31","author":"RA Haward","year":"2005","unstructured":"Haward RA, Morris E, Monson JR, Johnston C, Forman D. The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study. Eur J Surg Oncol. 2005;31:22\u20138.","journal-title":"Eur J Surg Oncol."},{"key":"2669_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.sla.0000167926.60908.15","volume":"242","author":"R Marr","year":"2005","unstructured":"Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74\u201382.","journal-title":"Ann Surg."},{"key":"2669_CR31","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ejca.2008.11.039","volume":"45","author":"M Dulk den","year":"2009","unstructured":"den Dulk M, Putter H, Collette L, Marijnen CA, Folkesson J, Bosset JF, et al. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer. 2009;45:1175\u201383.","journal-title":"Eur J Cancer."},{"key":"2669_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01.sla.0000232540.82364.43","volume":"245","author":"J Guillem","year":"2007","unstructured":"Guillem J, Chessin D, Shia J, Suriawinata A, Riedel E, Moore HG, et al. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy. Ann Surg. 2007;245:88\u201393.","journal-title":"Ann Surg."},{"key":"2669_CR33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"K Peeters","year":"2007","unstructured":"Peeters K, Marijnen C, Nagtegaal I, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6\u00a0years. Ann Surg. 2007;246:693\u2013701.","journal-title":"Ann Surg."},{"key":"2669_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijrobp.2010.05.019","volume":"81","author":"JH Lee","year":"2011","unstructured":"Lee JH, Kim SH, Kim J-G, Cho HM, Shim BY. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys. 2011;81:431\u20138.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2669_CR35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijrobp.2010.02.025","volume":"80","author":"L Moureau-Zabotto","year":"2011","unstructured":"Moureau-Zabotto L, Farnault B, Chaisemartin C, Esterni B, Lelong B, Viret F, et al. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2011;80:483\u201391.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2669_CR36","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1200\/JCO.2010.34.4911","volume":"29","author":"C Aschele","year":"2011","unstructured":"Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G, et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol. 2011;29:2773\u201380.","journal-title":"J Clin Oncol."},{"key":"2669_CR37","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","volume":"28","author":"J-P Gerard","year":"2010","unstructured":"Gerard J-P, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2. J Clin Oncol. 2010;28:1638\u201344.","journal-title":"J Clin Oncol."},{"key":"2669_CR38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijrobp.2009.07.1718","volume":"78","author":"C Weiss","year":"2010","unstructured":"Weiss C, Arnold D, Dellas K, Liersch T, Hipp M, Fietkau R, et al. Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I\u2013II trials. Int J Radiat Oncol Biol Phys. 2010;78:472\u20138.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2669_CR39","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1245\/s10434-008-9892-3","volume":"15","author":"H Tulchinsky","year":"2008","unstructured":"Tulchinsky H, Shmueli E, Figer A, Klausner J, Rabau M. An interval\u00a0>\u00a07\u00a0weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol. 2008;15:2661\u20137.","journal-title":"Ann Surg Oncol."},{"key":"2669_CR40","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1463-1318.2006.00990.x","volume":"8","author":"S Supiot","year":"2006","unstructured":"Supiot S, Bennouna J, Rio E, Meurette G, Bardet E, Buecher B, et al. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Dis. 2006;8:430\u20135.","journal-title":"Colorectal Dis."},{"key":"2669_CR41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10350-004-0827-1","volume":"48","author":"KM Bullard","year":"2005","unstructured":"Bullard KM, Trudel JL, Baxter NN, Rothenberger DA. Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum. 2005;48:438\u201343.","journal-title":"Dis Colon Rectum."},{"key":"2669_CR42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bjs.7739","volume":"99","author":"KL Mathis","year":"2012","unstructured":"Mathis KL, Larson DW, Dozois EJ, Cima RR, Huebner M, Haddock MG, et al. Outcomes following surgery without radiotherapy for rectal cancer. Br J Surg. 2012;99:137\u201343.","journal-title":"Br J Surg."},{"key":"2669_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02303772","volume":"5","author":"P Luna-Perez","year":"1998","unstructured":"Luna-Perez P, Arriola EL, Cuadra Y, Alvarado I, Quintero A. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma. Ann Surg Oncol. 1998;5:203\u20138.","journal-title":"Ann Surg Oncol."},{"key":"2669_CR44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10434-001-0311-2","volume":"8","author":"G Esposito","year":"2001","unstructured":"Esposito G, Pucciarelli S, Alaggio R, Giacomelli L, Marchiori E, Iaderosa GA, et al. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol. 2001;8:311\u20138.","journal-title":"Ann Surg Oncol."},{"key":"2669_CR45","first-page":"1685","volume":"3","author":"FR Spitz","year":"1997","unstructured":"Spitz FR, Giacco GG, Hess K, Larry L, Rich TA, Janjan N, et al. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer. Clin Cancer Res. 1997;3:1685\u201390.","journal-title":"Clin Cancer Res."},{"key":"2669_CR46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijrobp.2009.03.003","volume":"74","author":"JG Kuremsky","year":"2009","unstructured":"Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2009;74:673\u201388.","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2669-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2669-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T16:15:08Z","timestamp":1643472908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2669-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,26]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2669"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2669-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,26]]}}}